These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1115745)

  • 1. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus.
    Ginzler E; Sharon E; Diamond H; Kaplan D
    Arthritis Rheum; 1975; 18(1):27-34. PubMed ID: 1115745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic treatment of glomerular diseases. I. Effect of azathioprine on serum creatinine and proteinuria. Report from a Copenhagen Study Group of Renal Diseases.
    Balslov JT; Brun C; Jensen KB; Jorgensen F; Jorgensen HE; Larsen M; Lorenzen I; Thomsen AC
    Acta Med Scand; 1973 Jun; 193(6):483-91. PubMed ID: 4721957
    [No Abstract]   [Full Text] [Related]  

  • 4. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
    Hahn BH; Kantor OS; Osterland CK
    Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis.
    Sergent JS; Lockshin MD; Klempner MS; Lipsky BA
    Am J Med; 1975 May; 58(5):644-54. PubMed ID: 1130420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study.
    Sztejnbok M; Stewart A; Diamond H; Kaplan D
    Arthritis Rheum; 1971; 14(5):639-45. PubMed ID: 4106177
    [No Abstract]   [Full Text] [Related]  

  • 9. Azathioprine treatment of immunological renal disease.
    Adams DA; Gordon A; Maxwell MH
    JAMA; 1967 Feb; 199(7):459-63. PubMed ID: 6071277
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Ann Intern Med; 1972 Dec; 77(6):829-35. PubMed ID: 4566283
    [No Abstract]   [Full Text] [Related]  

  • 11. Deterioration of renal function after discontinuation of long-term prednisone-azathioprine therapy in primary renal disease.
    Levitt JI
    N Engl J Med; 1970 May; 282(20):1125-7. PubMed ID: 5439410
    [No Abstract]   [Full Text] [Related]  

  • 12. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy.
    Sharon E; Kaplan D; Diamond HS
    N Engl J Med; 1973 Jan; 288(3):122-4. PubMed ID: 4564983
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
    Walden PA; Philalithis PE; Joekes AM; Bagshawe KD
    Clin Nephrol; 1977 Jul; 8(1):317-20. PubMed ID: 577907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome.
    Lindeman RD; Pederson JA; Matter BJ; Laughlin LO; Mandal AK
    J Chronic Dis; 1976 Mar; 29(3):189-204. PubMed ID: 1262427
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic indices in lupus nephritis.
    Hecht B; Siegel N; Adler M; Kashgarian M; Hayslett JP
    Medicine (Baltimore); 1976 Mar; 55(2):163-81. PubMed ID: 1256313
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of subepidermal immune deposits in uninvolved skin of patients with systemic lupus erythematosus: a 10-year longitudinal study.
    Davis BM; Gilliam JN
    J Invest Dermatol; 1984 Oct; 83(4):242-7. PubMed ID: 6384375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and azathioprine in systemic lupus erythrmatosus.
    Sharon E; Jones J; Diamond H; Kaplan D
    Am J Obstet Gynecol; 1974 Jan; 118(1):25-8. PubMed ID: 4808868
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.